Boston Scientific to Present New Data on Advances in Chronic Pain Care at the 2022 North American Neuromodulation Society (NANS) Meeting

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25th North American Neuromodulation Society...

Related Keywords

Florida ,United States ,Boston ,Massachusetts ,Orlando ,Lauren Tengler ,Magdalena Anitescu ,Nilesh Kumar Patel ,Wavewriter Alpha ,Jessica Sachariason ,Mark Wallace ,Boston Scientific Corporation ,Twitter ,American Neuromodulation Society ,Ibm ,Boston Scientific ,Exchange Commission ,Prnewswire Boston Scientific Corporation ,Securities Exchange ,Facebook ,Center Evaluation Of Novel Fast ,Scientific Corporation ,North American Neuromodulation Society ,Spinal Cord Stimulator ,Control Trial ,Two Year Outcomes ,Simultaneous Delivery ,Multiple Modalities ,Chronic Pain Patients ,Multi Center Evaluation ,Novel Fast Acting Sub Perception Based ,Chronic Pain ,Multicenter Study ,Radiofrequency Ablation Outcomes ,Digital Tools ,Improve Access ,Treatment Efficiency ,Spinal Cord Stimulation ,Dorsal Column Axons ,Wide Dynamic Range Neurons ,Interspinous Spacers ,Boston Scientific Chronic Pain ,Fast Acting Sub Perception Therapy ,Radiofrequency Ablation ,Securities Act ,Securities Exchange Act ,Risk Factors ,Annual Report ,Quarterly Reports ,Body Guidelines ,Wavewriter Alpha Prime Spinal Cord Stimulator ,Indirect Decompression ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Medical Equipment ,